Genmab — August 2020

[Solsen]

Ja meget positivt,
at se at der er menneskeskæbner der nyder godt af Genmabs innovation. At vi andre nyder kursstigningerne blegner i den forbindelse.

[GeorgeBest]

Dejlig artikel, tak for den butterboy

[transalp]

Hold da op, dejlig læsning. Tak butterboy.. der er vitterlig meget godt i vente..

[E_L]

GEN1044 (DuoBody-CD3x5T4) started recruiting in July https://www.clinicaltrials.gov/ct2/history/NCT04424641?A=1&B=2&C=merged#StudyPageTop

[E_L]

GEN1046 still steadily adding locations, all recruiting https://www.clinicaltrials.gov/ct2/history/NCT03917381?A=9&B=10&C=merged#StudyPageTop

[E_L]

Enapotamab almost all recruiting as well https://www.clinicaltrials.gov/ct2/history/NCT02988817?A=16&B=17&C=merged#StudyPageTop

[Darvin]

Mht epcoritamab, så tåler denne genlæsning. “Jeg har aldrig set så potent et lægemiddel til den her type patienter“ og “ lige så effektiv som CART-T og mere sikker” https://haematologisktidsskrift.dk/sygdomme/lymfoma/720-subkutant-bispecifikt-cd3-cd20-antistof-mulig-konkurrent-til-car-t.html

[Don_Joning]

puha Darvin det er jo NSFW materiale du deler der

[Bulder]

De omtaler ikke den okulare toksicitet https://haematologisktidsskrift.dk/sygdomme/myeloma/739-dansk-optimisme-efter-ema-godkendelse-af-ny-myelomatose-behandling.html

[lahn1]

NSFW, Not Suitable For Minors ?

[nohope]

Normalt betyder det Not Suitable For Work(på Reddit), men hvorfor det skulle være det her, det aner jeg ikke.

[lahn1]

Nej det for mit ?

[lahn1]

Nej derfor mit ?

[E_L]

Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs https://investors.immatics.com/news-releases/news-release-details/immatics-announces-european-clinical-expansion-its-adoptive-cell

[E_L]

Immatics’ clinical product class ACTengine is a personalized approach for patients with advanced solid cancers. Patient’s own T cells are genetically modified to express a novel proprietary TCR cognate to one of Immatics’ cancer targets identified by its proprietary XPRESIDENT target discovery platform.

[E_L]

it is now 2 years ago that Genmab "gains exclusive access to multiple novel proprietary tumor targets identified by Immatics Biotechnologies’ XPRESIDENT technology" Would be nice if we could hear a bit on progress on CMD

[E_L]

No news yet from ADCT "Announced FDA lifted partial clinical hold on pivotal Phase 2 trial of Cami for relapsed or refractory Hodgkin lymphoma: In July 2020, the Company announced that the FDA had lifted the partial clinical hold on its pivotal Phase 2 clinical trial of camidanlumab tesirine (Cami, formerly ADCT-301) in patients with relapsed or refractory Hodgkin lymphoma (HL).

[E_L]

The Company continued to treat those patients who could benefit from ongoing treatment during the partial clinical hold, and the clinical trial is now open for enrollment. Interim results from the clinical trial are expected in the first half of 2021, subject to any impact by COVID-19. The clinical trial is intended to support the submission of a BLA to the FDA."

[BioShare]

Ja, det er møgirriterende Pens. Gode ideer til et bearcertifkat i USD?

[Legolas23]

Det kunne være et godt emne i debatforummet, som er beregnet til det